Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery

World Journal of Gastroenterology

Volumn 19, Issue 3, 2013, Pages 389-393

  Lou, Zheng ^a   Meng, Rong Gui ^a   Zhang, Wei ^a   Yu, En Da ^a   Fu, Chuan Gang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Metastasis; Pathologically T1; Risk factor

Indexed keywords

CARCINOEMBRYONIC ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84873736007     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i3.389     Document Type: Article

References (26)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31 [PMID: 10200775 DOI: 10.3322/canjclin.49.1.8]
2. Weinberg DS, Schoen RE. Colorectal cancer screening: America's next top model? Ann Intern Med 2012; 157: 673-674 [PMID: 23128867 DOI: 10.7326/0003-4819-157-9-201211060-00017]
3. Patel SS, Floyd A, Doorly MG, Ortega AE, Ault GT, Kaiser AM, Senagore AJ. Current controversies in the management of colon cancer. Curr Probl Surg 2012; 49: 398-460 [PMID: 22682507 DOI: 10.1067/j.cpsurg.2012.03.002]
4. Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol 2010; 40: 281-285 [PMID: 20085904 DOI: 10.1093/jjco/hyp187]
5. Wang JH, King TM, Chang MC, Hsu CW. Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis. World J Gastroenterol 2012; 18: 5427-5433 [PMID: 23082060 DOI: 10.3748/wjg.v18.i38.5427]
6. Iida S, Hasegawa H, Okabayashi K, Moritani K, Mukai M, Kitagawa Y. Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer. World J Surg 2012; 36: 424-430 [PMID: 22187130 DOI: 10.1007/s00268-011-1378-y]
7. Ramos-Esquivel A. Screening flexible sigmoidoscopy for colon cancer. N Engl J Med 2012; 367: 1064-1065; author reply 1065-1066 [PMID: 22970953 DOI: 10.1056/NEJMc1208513]
8. Okabe S, Shia J, Nash G, Wong WD, Guillem JG, Weiser MR, Temple L, Sugihara K, Paty PB. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 2004; 8: 1032-1039; discussion 1039-1040 [PMID: 15585391 DOI: 10.1016/j.gassur.2004.09.038]
9. Dias AR, Nahas CS, Marques CF, Nahas SC, Cecconello I. Transanal endoscopic microsurgery: indications, results and controversies. Tech Coloproctol 2009; 13: 105-111 [PMID: 19484350 DOI: 10.1007/s10151-009-0466-6]
10. Gao JY, Song BR, Peng JJ, Lu YM. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer. World J Gastroenterol 2012; 18: 5965-5971 [PMID: 23139614 DOI: 10.3748/wjg.v18.i41.5965]
11. Koca D, Binicier C, Oztop I, Yavuzsen T, Ellidokuz H, Yilmaz U. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer. J BUON 2012; 17: 291-298 [PMID: 22740208]
12. Suh JH, Han KS, Kim BC, Hong CW, Sohn DK, Chang HJ, Kim MJ, Park SC, Park JW, Choi HS, Oh JH. Predictors for lymph node metastasis in T1 colorectal cancer. Endoscopy 2012; 44: 590-595 [PMID: 22638780 DOI: 10.1055/s-0031-1291665]
13. Chang HC, Huang SC, Chen JS, Tang R, Changchien CR, Chiang JM, Yeh CY, Hsieh PS, Tsai WS, Hung HY, You JF. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol 2012; 19: 2477-2484 [PMID: 22396007 DOI: 10.1245/s10434-012-2303-9]
14. Mroczkowski P, Schmidt U, Sahm M, Gastinger I, Lippert H, Kube R. Prognostic factors assessed for 15,096 patients with colon cancer in stages I and II. World J Surg 2012; 36: 1693-1698 [PMID: 22411087 DOI: 10.1007/s00268-012-1531-2]
15. Stipa F, Giaccaglia V, Burza A. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer. Dis Colon Rectum 2012; 55: 262-269 [PMID: 22469792 DOI: 10.1097/DCR.0b013e318241ef22]
16. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Muto T. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 2007; 141: 67-75 [PMID: 17188169 DOI: 10.1016/j.surg.2006.07.020]
17. Shin R, Jeong SY, Yoo HY, Park KJ, Heo SC, Kang GH, Kim WH, Park JG. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum 2012; 55: 1220-1228 [PMID: 23135579 DOI: 10.1097/DCR.0b013e31826fea6a]
18. Lee SD, Kim TH, Kim DY, Baek JY, Kim SY, Chang HJ, Park SC, Park JW, Oh JH, Jung KH. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol 2012; 38: 478-483 [PMID: 22465588 DOI: 10.1016/j.ejso.2012.03.002]
19. Storli KE, Søndenaa K, Bukholm IR, Nesvik I, Bru T, Furnes B, Hjelmeland B, Iversen KB, Eide GE. Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age. Int J Colorectal Dis 2011; 26: 1299-1307 [PMID: 21562744 DOI: 10.1007/s00384-011-1244-2]
20. Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J Gastroenterol 2012; 18: 5489-5494 [PMID: 23112540 DOI: 10.3748/wjg.v18.i39.5489]
21. Nano M, Ferronato M, Solej M, D'Amico S. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Tumori 2006; 92: 469-473 [PMID: 17260485]
22. Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis 2009; 11: 157-161 [PMID: 18462239 DOI: 10.1111/j.1463-1318.2008.01556.x]
23. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Saito Y, Watanabe M, Morita T, Hida J, Ueno M, Ono M, Yasuno M, Sugihara K. Is total mesorectal excision always necessary for T1-T2 lower rectal cancer? Ann Surg Oncol 2010; 17: 973-980 [PMID: 19953330 DOI: 10.1245/s10434-009-0849-y]
24. Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 2010; 14: 1074-1080 [PMID: 20431977 DOI: 10.1007/s11605-010-1206-y]
25. Kobayashi H, Mochizuki H, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Sugihara K. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol 2011; 46: 203-211 [PMID: 21152938 DOI: 10.1007/s00535-010-0341-2]
26. Kim CH, Huh JW, Kim HJ, Lim SW, Song SY, Kim HR, Na KJ, Kim YJ. Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer. Dis Colon Rectum 2012; 55: 459-464 [PMID: 22426271 DOI: 10.1097/DCR.0b013e318246b08d]